Media/Publishing
Issue Code: MED
🤖
AI Overview
Media/Publishing is one of the 79 issue categories tracked under the Lobbying Disclosure Act. With $203.8M in total lobbying spend across 9,746 filings, it ranks among the significantly lobbied policy areas in Washington. The money flowing into this issue reflects how much is at stake for the industries involved.
$203.8M
Total Lobbying Spend
9,746
Filings
50
Top Clients
Spending by Year
| Year | Spending | Filings |
|---|---|---|
| 2018 | $19.4M | 995 |
| 2019 | $20.1M | 1,065 |
| 2020 | $26.3M | 1,359 |
| 2021 | $27.4M | 1,295 |
| 2022 | $29.4M | 1,364 |
| 2023 | $27.1M | 1,309 |
| 2024 | $24.2M | 1,123 |
| 2025 | $29.9M | 1,236 |
Biggest Spenders
| # | Client | Spending |
|---|---|---|
| 1 | Coalition of Epscor States | $3.6M |
| 2 | American Clinical Laboratory Association (Acla) | $2.8M |
| 3 | Mass General Brigham | $2.7M |
| 4 | Omeros Corporation | $2.4M |
| 5 | Alliance for Biosecurity | $2.4M |
| 6 | Air Liquide USA LLC | $2.3M |
| 7 | Travere Therapeutics | $2.3M |
| 8 | Public Access to Sunscreens (Pass) Coalition | $2.3M |
| 9 | Loma Linda University Medical Center | $2.1M |
| 10 | Uab Health System | $1.9M |
| 11 | Amgen USA, INC. | $1.8M |
| 12 | Seattle Children's Hospital Research and Foundation | $1.8M |
| 13 | Continuing Medical Education Coalition | $1.7M |
| 14 | Iqvia | $1.7M |
| 15 | Sanofi, U.S. | $1.7M |
| 16 | Children's National Medical Center | $1.6M |
| 17 | Astct | $1.6M |
| 18 | Medisys Health Network | $1.6M |
| 19 | Association for Molecular Pathology | $1.6M |
| 20 | Jazz Pharmaceuticals | $1.6M |
| 21 | Invitae INC. | $1.5M |
| 22 | Exela Pharma Sciences, LLC | $1.5M |
| 23 | American College of Radiology Association | $1.4M |
| 24 | Mississippi State University | $1.4M |
| 25 | University of Alabama System | $1.3M |
Top Firms
Van Scoyoc Associates$11.0M
Forbes-tate$7.1M
Squire Patton Boggs$5.3M
Ballard Partners$4.9M
Thorn Run Partners$3.9M
Capitol Counsel LLC$3.9M
Ipolicy Solutions$3.4M
Alston & Bird LLP$3.3M
What They Lobby For
- Raising Canndescent's profile in Washington, DC with federal decision makers; intellectual property issues before the US Patent and Trademark Office; promoting Canndescent's research and development o
- Development of government-private partnerships to advance Alzheimer's therapies.
- Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition.
- Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers
- Medicare payment for hyperbaric oxygen therapy; Use of hyperbaric oxygen therapy for treatment of PTSD and CTE; Research on effectiveness of HBOT for PTSD and CTE for active duty and retired and disab
- Issues related to payment and delivery reforms, Medicaid benefits and childrens hospital reimbursement. Issues related to pediatric research and childrens hospital graduate medical education.
- Issues related to FDA diagnostics approval process
- Veterans administration (structure, benefits, services, and quality of care) Family code (UCCJEA) Federal enforcement of parental rights. Veteran suicide epidemic (root causes, actions, programs, ac
- FY19 DoD Appropriations; FY19 Labor, HHS, Education Appropriations; FY19 NDAA; Issues related to autism research
- Federal government relations service, strategy development and implementation relating to companys status of FDA action on NDA for oral testosterone.
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.